Bayer AG (BAYRY) is considering selling its diabetes device business, which could fetch the Germany company up to EUR2 billion, Bloomberg News reported Monday on its website, citing people with knowledge of the matter.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.